These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9041333

  • 1. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection.
    Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C.
    J Infect Dis; 1997 Mar; 175(3):611-20. PubMed ID: 9041333
    [Abstract] [Full Text] [Related]

  • 2. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.
    Greatorex JS, Thorne GM.
    J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241
    [Abstract] [Full Text] [Related]

  • 3. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH, Lee YH, Lee SH, Lee SR, Huh JW, Kim SU, Chang KT.
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [Abstract] [Full Text] [Related]

  • 4. Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis.
    Flores FX, Jabs K, Thorne GM, Jaeger J, Linshaw MA, Somers MJ.
    Pediatr Nephrol; 1997 Aug; 11(4):488-90. PubMed ID: 9260252
    [Abstract] [Full Text] [Related]

  • 5. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB, Okuda J, Matsumoto C, Morigaki T, Asai N, Watanabe H, Nishibuchi M.
    FEMS Microbiol Lett; 1998 Sep 01; 166(1):43-8. PubMed ID: 9741083
    [Abstract] [Full Text] [Related]

  • 6. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A, Sacerdoti F, Seyahian EA, Amaral MM, Fiorentino G, Fernandez Brando R, Vilte DA, Mercado EC, Palermo MS, Cataldi A, Zotta E, Ibarra C.
    Vaccine; 2018 Mar 20; 36(13):1728-1735. PubMed ID: 29483033
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.
    Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD.
    Infect Immun; 1990 Dec 20; 58(12):3959-65. PubMed ID: 2254023
    [Abstract] [Full Text] [Related]

  • 10. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice.
    Barrett TJ, Potter ME, Wachsmuth IK.
    Infect Immun; 1989 Nov 20; 57(11):3434-7. PubMed ID: 2680974
    [Abstract] [Full Text] [Related]

  • 11. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
    Lopez EL, Diaz M, Grinstein S, Devoto S, Mendilaharzu F, Murray BE, Ashkenazi S, Rubeglio E, Woloj M, Vasquez M.
    J Infect Dis; 1989 Sep 20; 160(3):469-75. PubMed ID: 2668430
    [Abstract] [Full Text] [Related]

  • 12. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.
    Louise CB, Obrig TG.
    J Infect Dis; 1995 Nov 20; 172(5):1397-401. PubMed ID: 7594687
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME, Lupp C, Mascarenhas M, Vazquez A, Coombes BK, Brown NF, Coburn BA, Deng W, Puente JL, Karmali MA, Finlay BB.
    J Infect Dis; 2006 Sep 15; 194(6):819-27. PubMed ID: 16941350
    [Abstract] [Full Text] [Related]

  • 19. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
    Rahal EA, Kazzi N, Kanbar A, Abdelnoor AM, Matar GM.
    Int J Antimicrob Agents; 2011 Feb 15; 37(2):135-9. PubMed ID: 21129928
    [Abstract] [Full Text] [Related]

  • 20. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.
    Rüssmann H, Schmidt H, Heesemann J, Caprioli A, Karch H.
    J Med Microbiol; 1994 May 15; 40(5):338-43. PubMed ID: 7909850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.